Kamel M, Sroor F, Mahmoud K, Shafey H, Hassaneen H, Vendier L
RSC Adv. 2025; 15(8):6015-6031.
PMID: 40013064
PMC: 11862990.
DOI: 10.1039/d4ra08958h.
Glomb T, Minta J, Nowosadko M, Radzikowska J, Swiatek P
Molecules. 2025; 29(24.
PMID: 39770124
PMC: 11677506.
DOI: 10.3390/molecules29246036.
Majid M, Ganai B, Wani A
Curr Microbiol. 2024; 82(1):40.
PMID: 39680205
DOI: 10.1007/s00284-024-04023-x.
Fernandes C, Prestes A, Ianiski L, Maciel A, Noro B, da Silva F
Braz J Microbiol. 2024; 56(1):331-340.
PMID: 39666162
PMC: 11885195.
DOI: 10.1007/s42770-024-01572-y.
Navacchia M, Cinti C, Marchesi E, Perrone D
Molecules. 2024; 29(22).
PMID: 39598790
PMC: 11596935.
DOI: 10.3390/molecules29225403.
Can letrozole be repurposed for the treatment of visceral leishmaniasis?.
Ribeiro J, Teixeira E, Alves L, Alves E, Pascoal-Xavier M, Santi A
Antimicrob Agents Chemother. 2024; 68(11):e0075624.
PMID: 39387580
PMC: 11540148.
DOI: 10.1128/aac.00756-24.
Thiophene-Linked 1,2,4-Triazoles: Synthesis, Structural Insights and Antimicrobial and Chemotherapeutic Profiles.
El-Emam N, El-Ashmawy M, Mohamed A, Habib E, Thamotharan S, Abdelbaky M
Pharmaceuticals (Basel). 2024; 17(9).
PMID: 39338288
PMC: 11435084.
DOI: 10.3390/ph17091123.
Probing -substituted 4-(5-mercapto-4-ethyl-4H-1,2,4-triazol-3-yl)--phenylpiperdine-1-carboxamides as potent 15-LOX inhibitors supported with ADME, DFT calculations and molecular docking studies.
Nawaz Z, Riaz N, Saleem M, Iqbal A, Ejaz S, Muzaffar S
Heliyon. 2024; 10(17):e35278.
PMID: 39281606
PMC: 11401107.
DOI: 10.1016/j.heliyon.2024.e35278.
Synthesis of novel piperazine-based bis(thiazole)(1,3,4-thiadiazole) hybrids as anti-cancer agents through caspase-dependent apoptosis.
Mohamed D, Kheder N, Sharaky M, Nafie M, Dawood K, Abbas A
RSC Adv. 2024; 14(34):24992-25006.
PMID: 39131497
PMC: 11310838.
DOI: 10.1039/d4ra05091f.
An updated review on 1,2,3-/1,2,4-triazoles: synthesis and diverse range of biological potential.
Raman A, Aslam M, Awasthi A, Ansari A, Jain P, Lal K
Mol Divers. 2024; 29(1):899-964.
PMID: 39066993
DOI: 10.1007/s11030-024-10858-0.
Stereoselective Asymmetric Syntheses of Molecules with a 4,5-Dihydro-1-[1,2,4]-Triazoline Core Possessing an Acetylated Carbohydrate Appendage: Crystal Structure, Spectroscopy, and Pharmacology.
Al Maqbali A, Al Rasbi N, Zoghaib W, Sivakumar N, Robertson C, Shongwe M
Molecules. 2024; 29(12).
PMID: 38930904
PMC: 11206253.
DOI: 10.3390/molecules29122839.
Crystal structure of bis-{2-[5-(3,4,5-tri-meth-oxyphenyl)-4-1,2,4-triazol-3-yl]pyridine}palladium(II) bis-(tri-fluoro-acetate) tri-fluoro-acetic acid disolvate.
Zakharchenko B, Khomenko D, Doroshchuk R, Bargan A, Vassilyeva O, Lampeka R
Acta Crystallogr E Crystallogr Commun. 2024; 80(Pt 6):567-571.
PMID: 38845720
PMC: 11151322.
DOI: 10.1107/S205698902400392X.
NMI-SOCl-Mediated Amide Bond Formation: Facile Synthesis of Some Dihydrotriazolopyrimidine Amide Derivatives as Potential Anti-Inflammatory and Anti-Tubercular Agents.
Babu A, Sunil K, Sajith A, Reddy E, Santra S, Zyryanov G
Pharmaceuticals (Basel). 2024; 17(5).
PMID: 38794119
PMC: 11123900.
DOI: 10.3390/ph17050548.
A Review on Indole-triazole Molecular Hybrids as a Leading Edge in Drug Discovery: Current Landscape and Future Perspectives.
Rohilla S, Goyal G, Berwal P, Mathur N
Curr Top Med Chem. 2024; 24(18):1557-1588.
PMID: 38766822
DOI: 10.2174/0115680266307132240509065351.
Electrochemical Properties of Fused Pyrimidine-Triazole Heterocyclic Molecules as Novel Drug Candidates.
Kurul F, Istanbullu H, Kaya H, Cetin A, Topkaya S
Turk J Pharm Sci. 2024; 21(2):113-124.
PMID: 38742813
PMC: 11096787.
DOI: 10.4274/tjps.galenos.2023.46095.
Synthesis, Molecular Docking, and Biological Evaluation of Novel Indole-triazole Conjugates.
Berwal P, Rohilla S, Mathur N, Rani K
Curr Drug Discov Technol. 2024; 21(6):e120324227917.
PMID: 38482620
DOI: 10.2174/0115701638295739240222074426.
Modeling the Blood-Brain Barrier Permeability of Potential Heterocyclic Drugs via Biomimetic IAM Chromatography Technique Combined with QSAR Methodology.
Janicka M, Sztanke M, Sztanke K
Molecules. 2024; 29(2).
PMID: 38257200
PMC: 11154582.
DOI: 10.3390/molecules29020287.
Surfactin and Capric Acid Affect the Posaconazole Susceptibility of Strains with Altered Sterols and Sphingolipids Biosynthesis.
Derkacz D, Grzybowska M, Cebula L, Krasowska A
Int J Mol Sci. 2023; 24(24).
PMID: 38139328
PMC: 10743603.
DOI: 10.3390/ijms242417499.
Synthesis and Antibacterial Activity of Novel Triazolo[4,3-]pyrazine Derivatives.
Hu Z, Dong H, Si Z, Zhao Y, Liang Y
Molecules. 2023; 28(23).
PMID: 38067606
PMC: 10708386.
DOI: 10.3390/molecules28237876.
3D QSAR study on substituted 1, 2, 4 triazole derivatives as anticancer agents by kNN MFA approach.
Desai S, Mohite S, Alobid S, Saralaya M, Patil A, Das K
Saudi Pharm J. 2023; 31(12):101836.
PMID: 38028224
PMC: 10661185.
DOI: 10.1016/j.jsps.2023.101836.